NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/15/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization371.07 mln
Float47.22 mln
Earnings Date08/04/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
0.20
Very low leverage
ROE
-33.74
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Founded in 2016 and based in Seattle, Washington, Nautilus Biotechnology is an early-stage life sciences company building a technology platform designed to measure and analyze proteins at a highly detailed level. Its core product, the Nautilus Voyager Platform, combines specialized instruments, chemical reagents, and software to identify and quantify proteins found in biological samples. The company has established research partnerships with leading institutions including Genentech, Cornell University, and the Michael J. Fox Foundation to advance its work.
